Christopher Hourigan C, Dillon L, Logan B, et al. Impact of conditioning intensity of allogenic transplantation for acute myeloid leukemia with genomic evidence of residual disease. 24th Congress of EHA, abstract LB2600.
Rituximab of obinutuzumab of plus CHOP bij nieuw-gediagnostiseerd DLBCL
aug 2017 | Lymfoom